Skip to Content

Antibodies, Volume 15, Issue 2

2026 April - 21 articles

Cover Story: This investigation reveals distinct tissue-specific patterns of FcRn-mediated mAb distribution within the eye. FcRn binding significantly enhanced antibody distribution in ocular tissues, such as the iris–ciliary body, and tears, with less pronounced effects on the retina, cornea, conjunctiva and aqueous humor. These findings provide mechanistic insights for optimizing mAb-based therapeutics for ocular disease and understanding the ocular toxicity of mAb-based therapeutics, such as antibody–drug conjugates. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Article
  • Open Access
2,185 Views
21 Pages

A Recombinant Antibody Against Human DRP1 Serine 616 Phosphorylation Enables Detection of BRAFV600E-Associated Mitochondrial Division in Cancer

  • Shanon T. Nizard,
  • Yiyang Chen,
  • Madhavika N. Serasinghe,
  • Ruben Fernandez-Rodriguez and ,
  • Kamrin D. Shultz,
  • Jesminara Khatun,
  • Anthony Mendoza,
  • Jesse D. Gelles,
  • Juan F. Henao-Martinez and
  • Jerry Edward Chipuk
  • + 11 authors+ 6 authors

20 April 2026

Background/Objectives: Mitochondria are dynamic organelles that continuously undergo balanced cycles of fusion and division to maintain optimal function. Mitochondrial division is mediated by Dynamin-Related Protein 1 (DRP1), a cytosolic large GTPase...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
3 Citations
3,672 Views
16 Pages

17 April 2026

Antibodies directed against β-amyloid (Aβ) have been developed for the treatment of Alzheimer’s disease (AD). However, the in vivo central efficacy is reduced by the poor penetration of antibodies across the blood–brain barrier...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
2,887 Views
20 Pages

16 April 2026

The treatment paradigm for HER2-positive metastatic breast cancer has evolved from continuous chemotherapy-based regimens to a model of finite chemotherapy induction followed by sustained antibody-driven disease control. The CLEOPATRA trial establish...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Review
  • Open Access
2 Citations
2,922 Views
56 Pages

15 April 2026

The immunoglobulins (IG) or antibodies and the T cell receptors (TR) are the antigen receptors of the adaptive immune responses (AIR) of jawed vertebrates (Gnathostomata). IMGT®, the international ImMunoGeneTics information system®, was creat...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
2,585 Views
15 Pages

13 April 2026

Background: Transferrin receptor protein 1 (TfR1) plays a central role in cellular iron uptake and is frequently overexpressed in malignant tumor cells, rendering it an attractive target for tumor-directed therapy and drug delivery. Methods: A fully...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Review
  • Open Access
1,385 Views
12 Pages

Non-COVID-19 Vaccinations and the Induction of Autoantibodies in Pemphigus Diseases: A Review of the Speculative Issue and Our Clinical-Laboratory Experience

  • Maksymilian Markwitz,
  • Natalia Welc,
  • Klementyna Kępińska,
  • Monika Bowszyc-Dmochowska and
  • Marian Dmochowski

10 April 2026

Background: Pemphigus diseases are rare autoimmune blistering disorders mediated by pathogenic autoantibodies directed mainly against desmoglein 1 and desmoglein 3. Although most cases are considered idiopathic, external triggers that can disrupt imm...

(This article belongs to the Section Humoral Immunity)
  • Case Report
  • Open Access
1,267 Views
12 Pages

Monoclonal Antibodies in Pregnancy of Patients with Systemic Lupus Erythematosus: Friend or Foe? A Case Report of a Patient with Multiple Pregnancies

  • Chiara Orlandi,
  • Angela Tincani,
  • Micaela Fredi,
  • Laura Andreoli and ,
  • Francesca Crisafulli,
  • Liala Moschetti,
  • Cecilia Nalli,
  • Maria Grazia Lazzaroni,
  • Marco Taglietti and
  • Ilaria Cavazzana
  • + 9 authors+ 4 authors

Systemic lupus erythematosus (SLE) is an autoimmune disease that predominantly affects women of childbearing age, and active disease during pregnancy is associated with increased maternal and fetal morbidity. Belimumab is an effective biologic therap...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Review
  • Open Access
2,113 Views
11 Pages

The Possible Role of Antibodies in Alopecia: A Narrative Review

  • Julia Cieślawska,
  • Mariola Pawlaczyk and
  • Justyna Gornowicz-Porowska

Human hair performs a number of important physiological and esthetic functions. Hair loss and alopecia are complex disorders which affect people all over the world. Hair loss can be an early manifestation of various autoimmunological disorders. Despi...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
1,937 Views
14 Pages

SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIV

  • Sharon L. Walmsley,
  • Leif Erik Lovblom,
  • Bryan Boyachuk,
  • Curtis Cooper and ,
  • Valérie Martel-Laferrière,
  • Mona Loutfy,
  • Marie-Louise Vachon,
  • Shariq Haider,
  • Pamela Aldebes and
  • Marina B. Klein
  • + 8 authors+ 3 authors

Objectives: To determine the incidence and outcomes of SARS-CoV-2 infection and to evaluate seroconversion rates and quantify antibody responses to COVID-19 vaccines in two cohorts of persons living with HIV at a possible higher risk of poor outcomes...

(This article belongs to the Special Issue Antiviral Antibody Immune Responses in the Context of Vaccination and Infection)
  • Article
  • Open Access
2,991 Views
36 Pages

Development of Bispecific Antibody Targeting Human IL-17A and IL-6

  • Beata Pamuła,
  • Martyna Banach,
  • Marta Mikońska,
  • Karolina Korytkowska and ,
  • Krzysztof Lacek,
  • Oliwia Śniadała,
  • Małgorzata Marczak,
  • Krzysztof Flis,
  • Aleksandra Sowińska and
  • Olga Abramczyk
  • + 9 authors+ 4 authors

30 March 2026

Background/Objectives: Antibodies are a rapidly expanding field in drug discovery, but their monospecificity limits therapeutic applications, particularly in complex inflammatory diseases. Multispecific therapeutics, which combine variable regions ta...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Review
  • Open Access
2,198 Views
13 Pages

27 March 2026

Invasive candidiasis (IC) remains a significant cause of morbidity and mortality among critically ill, hematologic, and neonatal patients worldwide. Rapid and accurate diagnosis is essential to guide timely antifungal therapy and improve outcomes. Am...

  • Article
  • Open Access
1 Citations
2,726 Views
19 Pages

The Effect of FcRn Binding on Ocular Disposition of Monoclonal Antibodies

  • Sanika Naware,
  • Saurav Kulkarni,
  • Sahil Salvi,
  • Dhvani Patel and
  • Dhaval K. Shah

25 March 2026

Background/Objectives: The neonatal Fc receptor (FcRn) plays a crucial role in extending the systemic half-life of monoclonal antibodies (mAbs), but its influence on ocular distribution remains incompletely understood. This study investigated the imp...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
2 Citations
2,318 Views
20 Pages

The Multi-Attribute Method (MAM), An Advanced LC-MS Approach for Protein A Resin Performance and Lifecycle Evaluation

  • Jingming Zhang,
  • Matthew Larsen,
  • Timothy Blanc,
  • Babita S. Parekh and
  • Ming-Ching Hsieh

23 March 2026

Background: Protein A resins are indispensable for monoclonal antibody (mAb) production, yet their condition and performance are traditionally assessed using indirect or qualitative methods. In this study, the multi-attribute method (MAM), previously...

(This article belongs to the Section Antibody-Based Therapeutics)
  • Article
  • Open Access
1 Citations
1,221 Views
15 Pages

Immunogenetic Architecture of Chronic Lymphocytic Leukemia at Early Stage: Insights from the O-CLL1 Cohort

  • Davide Bagnara,
  • Andrea Nicola Mazzarello,
  • Monica Colombo,
  • Ennio Nano and ,
  • Niccolò Cardente,
  • Fabiana Ferrero,
  • Nadia Bertola,
  • Vanessa Cossu,
  • Fabio Ghiotto and
  • Franco Fais
  • + 12 authors+ 7 authors

18 March 2026

Background/Objectives: The immunoglobulin heavy-chain variable (IGHV) gene repertoire represents a characteristic feature of chronic lymphocytic leukemia (CLL), although its configuration is not well defined at the early disease stages. The IGHV repe...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Review
  • Open Access
2,541 Views
12 Pages

Dermatomyositis with Anti-MDA5 Autoantibodies After SARS-CoV-2 mRNA Vaccination Treated with Tofacitinib: Integrating Literature Evidence and a Novel Observation

  • Maurizio Benucci,
  • Elisa Cioffi,
  • Francesca Li Gobbi,
  • Emanuele Antonio Maria Cassarà and ,
  • Riccardo Terenzi,
  • Edda Russo,
  • Valentina Grossi,
  • Barbara Lari,
  • Maria Infantino and
  • Mariangela Manfredi
  • + 5 authors+ 0 author

COVID-19 mRNA vaccines activate type I interferon pathways and in genetically or immunologically predisposed individuals may trigger autoimmune responses, including autoantibodies against melanoma differentiation-associated protein 5 (MDA5). Although...

(This article belongs to the Section Humoral Immunity)
  • Article
  • Open Access
2 Citations
3,276 Views
11 Pages

Evaluation of Anti-dsDNA Antibodies in Laboratory Practice: Management of Different Analytical Methods and Correlation with HEp-2 Immunofluorescence Patterns

  • Massimo Papale,
  • Carmela Paolillo,
  • Loredana Iafelice,
  • Tiziana Trivisano and ,
  • Giuseppe Stefano Netti,
  • Elena Ranieri and
  • Gaetano Corso
  • + 2 authors+ 0 author

Background: Anti-double-stranded DNA (anti-dsDNA) antibodies are a key serological marker for systemic lupus erythematosus (SLE) and are commonly assessed in conjunction with anti-nuclear antibody (ANA) testing by indirect immunofluorescence (IIF) on...

(This article belongs to the Section Antibody-Based Diagnostics)
  • Article
  • Open Access
2,204 Views
21 Pages

Developability Evaluation of Single-Domain Antibody-Chelator Conjugates for Diagnostic Radiotracers

  • Philipp D. Kaiser,
  • Simon Straß,
  • Sandra Maier,
  • Evgenia Herbold and ,
  • Bjoern Traenkle and
  • Anne Zeck
  • + 1 author+ 0 author

Background/Objectives: Developability assessment is a critical step in advancing antibody-based molecules toward clinical application. This evaluation typically begins during clinical candidate selection and continues throughout all modifications of...

(This article belongs to the Special Issue Therapeutic Antibodies: New Trends in Discovery, Developability and Characterization)
  • Article
  • Open Access
1 Citations
2,124 Views
18 Pages

Two Highly Specific Mouse Monoclonal Antibodies to the Putative C-Telopeptide of Human Collagen XIα1, a Cancer Biomarker

  • Marcos García-Ocaña,
  • Lorea Legazpi-Olabide,
  • Sandra Rodríguez-Rodero,
  • Paula Rodríguez-Folgueira and ,
  • Iván Fernández-Vega,
  • Marcos Ladreda-Mochales,
  • Juan R. de los Toyos and
  • Luis J. García-Flórez
  • + 3 authors+ 0 author

25 February 2026

Background: Collagen XIα1, encoded by the COL11A1 gene, is a minor fibrillar collagen that is overexpressed in various human cancers, in which its presence correlates with tumor aggressiveness and progression. Methods: In this study, we develop...

(This article belongs to the Section Antibody Discovery and Engineering)
  • Article
  • Open Access
1,368 Views
13 Pages

Prevalence of Viral Hepatitis Antibodies Among Alcoholics in Croatia: A Single Center’s Results

  • Maja Vilibić,
  • Klara Barbić,
  • Maja Bogdanić,
  • Snježana Židovec-Lepej and ,
  • Ana Matošić,
  • Ana Sanković,
  • Dalibor Karlović,
  • Leona Radmanić Matotek,
  • Nataša Kutela and
  • Tatjana Vilibić-Čavlek
  • + 12 authors+ 7 authors

25 February 2026

Background/Objectives: Viral hepatitis A–E represents a significant public health problem. Data on the prevalence of viral hepatitis markers among alcoholics are inconsistent. Methods: The study included 151 patients treated for alcohol abuse i...

(This article belongs to the Section Humoral Immunity)
  • Article
  • Open Access
1,874 Views
13 Pages

Camelid-Derived Nanobodies Targeting Human Epidermal Growth Factor Receptor: Screening, Expression, and Functional Validation

  • Yunfeng Liu,
  • Qiting Huang,
  • Dongna Zhang,
  • Yingjun Wang and ,
  • Shuaiying Zhao,
  • Jianchuan Wen,
  • Yingying Kong and
  • Jianfeng Xu
  • + 3 authors+ 0 author

24 February 2026

Objectives: The epidermal growth factor receptor (EGFR) is a clinically relevant membrane receptor that is frequently overexpressed or dysregulated in multiple types of cancer, making it an important target for antibody-based strategies. Nanobodies,...

(This article belongs to the Topic Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment)
  • Article
  • Open Access
2,646 Views
16 Pages

Discovery of Anti-SARS-CoV-2 XBB.1.5 and JN.1 Variant-Specific Monoclonal Single-Domain Antibodies from a Synthetic Library

  • Isamu Tsuji,
  • Kumiko Okada,
  • Benjamin Kroppen,
  • Tetsufumi Katta and ,
  • Kaori Yamamura,
  • Takeshi Nishihama,
  • Ayako Miura,
  • Hansjörg Götzke,
  • Eric Crampon and
  • Andrea Bertolotti-Ciarlet
  • + 5 authors+ 0 author

24 February 2026

Background/Objectives: The SARS-CoV-2 virus frequently undergoes mutations to evade the human immune system. Vaccines for new strains are developed each season, and an identification test confirming the specific strain is essential for vaccine qualit...

(This article belongs to the Section Antibody Discovery and Engineering)
XFacebookLinkedIn
Antibodies - ISSN 2073-4468